J K Dale - JoVE Visualize

Showing results (21-30 of 39) with videos related to

Pageof 4

Sort By:

Annals of Surgery|May 1, 1982

The importance of early diagnosis in patients with hereditary medullary thyroid carcinomaS A Wells, S B Baylin, G S Leight, et al.

Psychiatry Research|April 16, 1998

Lack of seasonal variation of symptoms in patients with chronic fatigue syndromeD García-Borreguero, J K Dale, N E Rosenthal, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1996

Periodic illness associated with Epstein-Barr virus infectionJ A Lekstrom-Himes, J K Dale, D W Kingma, et al.

The New England Journal of Medicine|December 29, 1988

Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trialS E Straus, J K Dale, M Tobi, et al.

Psychological Medicine|September 7, 2002

Using an interleukin-6 challenge to evaluate neuropsychological performance in chronic fatigue syndromeM C Arnold, D A Papanicolaou, J A O'Grady, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997

Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunityI J Fuss, W Strober, J K Dale, et al.

Neurology|December 1, 1996

Decreased postexercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depressionA Samii, E M Wassermann, K Ikoma, et al.

The Journal of Clinical Endocrinology and Metabolism|December 1, 1991

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndromeM A Demitrack, J K Dale, S E Straus, et al.

Psychiatry Research|July 25, 2000

Self-reported sensitivity to chemical exposures in five clinical populations and healthy controlsS S Nawab, C S Miller, J K Dale, et al.

Clinical Immunology (Orlando, Fla.)|August 22, 2001

TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesisJ J Bleesing, M R Brown, J K Dale, et al.

Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:

Pageof 4

Annals of Surgery|May 1, 1982

The importance of early diagnosis in patients with hereditary medullary thyroid carcinomaS A Wells, S B Baylin, G S Leight, et al.

Psychiatry Research|April 16, 1998

Lack of seasonal variation of symptoms in patients with chronic fatigue syndromeD García-Borreguero, J K Dale, N E Rosenthal, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1996

Periodic illness associated with Epstein-Barr virus infectionJ A Lekstrom-Himes, J K Dale, D W Kingma, et al.

The New England Journal of Medicine|December 29, 1988

Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trialS E Straus, J K Dale, M Tobi, et al.

Psychological Medicine|September 7, 2002

Using an interleukin-6 challenge to evaluate neuropsychological performance in chronic fatigue syndromeM C Arnold, D A Papanicolaou, J A O'Grady, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997

Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunityI J Fuss, W Strober, J K Dale, et al.

Neurology|December 1, 1996

Decreased postexercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depressionA Samii, E M Wassermann, K Ikoma, et al.

The Journal of Clinical Endocrinology and Metabolism|December 1, 1991

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndromeM A Demitrack, J K Dale, S E Straus, et al.

Psychiatry Research|July 25, 2000

Self-reported sensitivity to chemical exposures in five clinical populations and healthy controlsS S Nawab, C S Miller, J K Dale, et al.

Clinical Immunology (Orlando, Fla.)|August 22, 2001

TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesisJ J Bleesing, M R Brown, J K Dale, et al.

Pageof 4